Getting to Know Superbugs: C. diff
Clostridium difficile, or C.diff as it’s commonly known, is one of the fastest growing superbugs in the world. According to the Centers for Disease Control, there are more than 500,000 C. diff cases reported and more than 29,000 C. diff-related deaths each year within 30 days of diagnosis. C. diff incidences and related deaths have continued to climb since 1999 and today cost up to $4.8 billion each year in excess health care costs for acute care facilities alone.
Found in hospitals, clinics and other health care facilities, the infectious disease is extremely hard to kill and resistant to many antibiotics and traditional cleaning chemicals. As C. diff incidences continue to increase, many hospitals are turning to enhanced cleaning strategies that can help reduce the spread of infectious diseases such as C. diff, MERS, MRSA and others. That’s where Tru-D comes in.
Tru-D is a UVC disinfection robot that combats HAIs in health care facilities, including C. diff. Using measured doses of UV light, the germ-fighting robot takes the minimum time necessary to provide total room disinfection from one, single position, killing up to 99.9% of pathogens in the space. In fact, Becker’s Clinical Quality & Infection Control reported the success of a study conducted at a Veterans Affairs hospital involving Tru-D that reduced the amount of C. diff rates by 89%.
“C. diff continues to be a major issue for hospitals and patients—costing hospitals precious dollars and affecting the lives of hundreds of thousands of patients,” said Chuck Dunn, president and CEO of Tru-D SmartUVC. “Tru-d has been clinically proven to help reduce the spread of C. diff and other multidrug-resistant organisms, and we are committed to helping hospitals combat and reduce the incidences of such infectious diseases.”
For more information, click here.